Literature DB >> 28921283

Responses of interleukin-6 and tumor necrosis factor during and after cardiac surgery undergoing cardiopulmonary bypass and pancreatoduodenectomy.

Mitsuhiro Nishimura1, Kazuo Abe1, Tetsuo Sakakibara2, Kazuyasu Nakao3, Ikuto Yoshiya4.   

Abstract

To evaluate the effect of cardiopulmonary bypass on immunological function, we measured interleukin-6 (IL-6) and tumor necrosis factor (TNF) in 12 patients undergoing cardiac surgery during and after cardiopulmonary bypass, and in 10 patients with pancreatoduodenectomy. Plasma IL-6 levels were determined using the Human Interleukin 6 ELISA Kit, and TNF levels were determined using a highly sensitive sandwich enzyme immunoassay. In patients with cardiac surgery, plasma levels of IL-6 and TNF increased during cardiopulmonary bypass, and in patients with pancreatoduodenectomy, IL-6 and TNF levels significantly increased at the end of intraabdominal manipulation. These results suggest that endotoxin may have activated the immune system and stimulated cytokine production after pancreatoduodenectomy and during bypass.

Entities:  

Keywords:  Cardiac surgery; Interleukin-6; Pancreatodoudenectomy; Tumor necrosis factor

Year:  1995        PMID: 28921283     DOI: 10.1007/BF02479846

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

1.  Augmentation of interleukin-2 production after cardiac operations in patients treated with erythropoietin.

Authors:  K Hisatomi; T Isomura; S J Galli; H Yasunaga; N Hayashida; K Ohishi
Journal:  J Thorac Cardiovasc Surg       Date:  1992-08       Impact factor: 5.209

Review 2.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.

Authors:  S H Zuckerman; J Shellhaas; L D Butler
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

4.  Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.

Authors:  Y Fong; L L Moldawer; M Marano; H Wei; S B Tatter; R H Clarick; U Santhanam; D Sherris; L T May; P B Sehgal
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

5.  The effect of cardiopulmonary bypass on T cells and their subpopulations.

Authors:  H Ide; T Kakiuchi; N Furuta; H Matsumoto; K Sudo; A Furuse; K Asano
Journal:  Ann Thorac Surg       Date:  1987-09       Impact factor: 4.330

6.  Early plasma protein and mineral changes after surgery: a two stage process.

Authors:  M A Myers; A Fleck; B Sampson; C M Colley; J Bent; G Hall
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

7.  Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy.

Authors:  N Lahat; A Y Zlotnick; R Shtiller; I Bar; G Merin
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

8.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.

Authors:  K Saukkonen; S Sande; C Cioffe; S Wolpe; B Sherry; A Cerami; E Tuomanen
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Authors:  C Natanson; P W Eichenholz; R L Danner; P Q Eichacker; W D Hoffman; G C Kuo; S M Banks; T J MacVittie; J E Parrillo
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.